Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines  by Montinaro, Vincenzo et al.
Kidney International, VoL 47 (1995), pp. 829-836
CLINICAL INVESTIGATION
Biosynthesis of C3 by human mesangial cells. Modulation by
proinflammatory cytokines
VINCENZO MONTINARO, LEONARDO SERRA, SABRINA PERIssurrI, ELENA RANIERI, FRANCESCO TEDESCO,
and FRANCESCO PAOLO SCHENA
Division of Nephrology, University of Ban, "Istituto per l'Infanzia", Trieste and Istituto di Patologia Generale, Universitd di Trieste, Italy
Biosynthesis of C3 by human mesangial cells. Modulation by prom-
flammatory cytokines. Deposits of complement (C) components are found
in the glomeruli of patients with various glomerulonephritides without
detectable immunoglobulins, thus suggesting a pathogenetic role of the
locally produced proteins of this system. In the present study, we have
examined human mesangial cells (HMC) for their ability to secrete C3.
Three different cell lines were examined and all showed a basal production
of C3, which was up-regulated following stimulation with IL-i/3. IL-6 had
no direct stimulatory effect on its own, but synergized with IL-i to induce
an increased production of C3 in the culture supernatant and its relative
amount was confirmed by SDS-PAGE and immunoblot. Another agonist
such as lipopolysaccharide was not able to induce any significant C3
synthesis. Analysis of C3 HMC gene expression, performed by both
reverse transcription-polymerase chain reaction of isolated RNA and
Northern blot, confirmed the parallel increase of the specific transcript
under IL-i /3 and IL-i/3 + IL-6 stimulation. From these data we conclude
that production of C3 in the mesangium could have a pathophysiologic
relevance.
The complement (C) system has been implicated in the onset of
renal damage in various forms of glomerulonephritides [1] and in
experimental models of immune glomerular injury [2]. Tissue
damage is mediated through the generation of C-derived prom-
fiammatory products or is directly induced by the lytic terminal C
complex [1.
The C components responsible for renal tissue injury mostly
derive from the liver, since the bulk of circulating C proteins is
produced by hepatocytes [4, 5]. The activity of these cells has been
shown to be under regulatory controls of various cytokines
including IL-i, TNF and IL-6 [6, 7]. However, other cell types
have been found to synthesize C components, thus providing an
extrahepatic source of C that can also be modulated by cytokines
[7].
The report by Falus et al [8] that the kidneys of mice treated
with IL-i and LPS express the genes of C2, factor B and C3 and
actively produce the corresponding proteins, indicates that this
organ is one of the extrahepatic sites of C production. In addition,
gene expression of components of the classical and alternative C
pathways observed in lupus-prone mice (NZB/W and MRL
lpr/lpr) is related to the degree of mononuclear cell infiltration and
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hence to the development of nephritis [9, 10], further emphasizing
the contribution of locally produced C components to tissue
damage.
The establishment of optimal culture conditions for renal cells
has allowed investigations on their ability to synthesize C compo-
nents. Thus, proximal tubular epithelial cells have been shown to
secrete C4 and C3, particularly following stimulation by interfer-
ou-y and IL-2 [11, 12] and glomerular epithelial cells also
synthesize C proteins [13]. As to the mesangial cells, there is clear
evidence that they release C8 binding protein [14] and decay
accelerating factor [15], two regulatory proteins that inhibit the
activity of the CSb-9 complex and C3 convertase, respectively [16,
17].
The purpose of this investigation was to examine the ability of
human mesangial cells (HMC), obtained from different donors, to
secrete C3. The modulatory effect of cytokines on the production
of the proteins was also investigated.
Methods
Reagents
Standard cell culture reagents were obtained from different
suppliers. Fetal bovine serum (FBS) was purchased from 1-lyClone
(Logan, Utah, USA) and decomplemented for 30 minutes at 56°C
before use. RPMI, Hank's balanced salt solution (HBSS), bovine
insulin, L-glutamine, transferrin, sodium selenite, Hepes were
obtained from Sigma Chemical Co. (St. Louis, MO, USA).
Penicillin and streptomycin were purchased from Gibco Labora-
tories (Grand Island, NY, USA). Sodium pyruvate was purchased
from ICN Biomedicals (Costa Mesa, CA, USA), while non-
essential amino acids were obtained from Seromed (Munich,
Germany).
Guanidinium isothiocynate was obtained from BRL Life Tech-
nologies (Gaithersburg, MD, USA), and Sarcosyl was from Sigma
Chemical Co.
Complement components and antisera
Purified C3, was purchased from Quinlan (La Jolla, CA, USA),
which provided also monospecific goat IgG antibodies to human
C3.
Polyclonal rabbit anti-human fibronectin and laminin were
obtained from BRL Life Technologies, rabbit anti-desmin was
purchased from Sigma Chemical Co., anti-vimentin was obtained
from Polysciences (Warrington, PA, USA) and anti-factor VIII
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was provided by Boehringer Mannheim (Mannheim, Germany).
Monoclonal anti-cytokeratin was purchased from Triton Bio-
sciences (San Diego, CA, USA) and anti-macrophage antigen was
obtained from Dakopatts (Glostrup, Denmark).
Biotin-labeling of antibodies
Goat IgG to C3 was biotin-labeled according to a previously
reported procedure [18] with the only modifications that IgG was
dialyzed against 0.1 M sodium bicarbonate buffer pH 8.8 contain-
ing 0.1 M NaC1 and was subsequently mixed with D-biotin-N-
hydroxysuccinimide ester (Sigma Chemical Co.) at the ratio of 10
to 1 (wt/wt).
Cytokines
The cytokines used in this study were recombinant human
IL-lp and IL-6. IL-lp was obtained through the courtesy of Prof.
N. Semeraro (Institute of General Pathology, University of Ban,
Ban, Italy). Specific activity (assessed by the murine thymocyte
mitogenicity assay) was 2.0 X i07 U/mg protein. IL-6 was pur-
chased from Boehringer Mannheim.
Isolation of mesangial cells
Normal portions of renal cortex from kidneys removed for
carcinoma were used. Glomeruli were isolated by a standard
sieving technique through graded mesh size screens. The last
passage was performed onto a nylon 70 tm pore-size screen which
retained the glomeruli and allowed small tubular fragments and
isolated cells to pass through. Glomeruli, decapsulated by forced
flow through a 19 gauge needle, were treated by gentle collage-
nase type IV digestion (750 U/mi in HBSS) for 15 minutes at
37°C. Thereafter, they were plated onto 10 cm Petri dishes in
RPM! 1640 supplemented with 17% FBS, 2 mrvi L-glutamine,
antibiotics (streptomycin, 100 g/ml, penicillin, 100 U/mI), 2 mM
pyruvate, non-essential amino acids, insulin (5 jsglml), transferrin
(5 ng/ml), sodium selenite (5 nglml) and 25 mrvi Hepes (complete
medium). Outgrowth of mesangial cells was observed after four to
five days of culture, and homogeneous cultures were obtained
after the first passage.
Characterization of cultured mesangial cells
Purity of cell cultures was checked by immunoperoxidase
staining with monoclonal (cytokeratin, macrophage antigen) and
polyclonal (factor VIII, desmin, fibronectin, laminin) antibodies.
Briefly, HMC were grown to confluence onto glass slides, fixed in
formalin for 10 minutes, and after washing in PBS were incubated
for 30 minutes with the specific antibody at the appropriate
dilution. The slides were then washed in PBS and subsequently
exposed to biotinylated secondary antibody (goat anti-mouse or
anti-rabbit) for further 30 minutes. The bound biotin was allowed
to react with avidin-biotin complex (Vectastain ABC kit, Vector
Laboratories; Burlingame, CA, USA) and the enzymatic reaction
was developed using as substrate DAB and H202. The purity of
HMC was confirmed by its negative reaction with cytokeratin
(epithelial), factor VIII (endothelial) or a membrane marker of
monocytes, and, by contrast, for their positive reaction with
antibodies to desmin, fibronectin, vimentin and laminin.
Immunohistochemistiy staining for monocytes
To further confirm the absence of contaminating monocytes-
macrophages within HMC cultures an immunochemistry tech-
nique based on the APAAP method was performed as previously
described [19]. Briefly, HMC were grown onto plastic slides, at
subconfluence the medium was removed, the slides were washed
thrice with Hank's balanced salt solution and, after air drying,
were fixed by brief immersion in ice-cold acetone. Positive control
slides were prepared with peritoneal macrophages isolated by
sequential centrifugation and plastic adhesion of the peritoneal
exchange fluid from a patient treated by CAPD. To maximize DR
expression, macrophages were stimulated for 24 hours with LPS
(1 g/ml).
The primary antibody was a mouse monoclonal anti-human
invariant DR antigen (Technogenetics, Cassina de' Pecchi, Mi-
lano, Italy). Immobilized antibodies were detected by immunoal-
kaline phosphatase (APAAP) with affinity purified rabbit anti-
mouse immunoglobulin serum (Dakopatts) and APAAP complex
(1:50 dilution). Alkaline phosphatase was developed by New
Fuchsin (Sigma).
Cell culture experiments
Pure HMC cultures between passages 3 and 7 were allowed to
grow to near confluence in complete medium, and then kept in
resting conditions for 24 hours in a basal medium made of RPM!
1640, 0.5% FBS, 2 mrvi L-glutamine, 2 m sodium pyruvate, pool
of antibiotics and non-essential aminoacids. To exclude the pos-
sible interference of proteins present in FBS on the C3 ELISA, in
some experiments cells were also maintained, after confluence, in
a basal medium composed as above with the substitution of FBS
0.5% with BSA 0.1%.
Human recombinant IL-1/3 or IL-6 were added to HMC at
concentrations of 10, 100 or 1000 U/mI in a basal medium. The
cells were kept in culture for 72 hours and the supernatant was
harvested afterward. The combined effect of IL-1J3 (10 U/mI) and
IL-6 (1000 U/mi) was also evaluated.
Experiments were conducted to assess the eventual agonistic
effect of lipopolysaccharide (LPS) on C3 synthesis. For this reason
HMC were stimulated for 72 hours with LPS from E. coli at
concentration of 0.1 or 1 g/m1.
Finally, in some experiments with cytokines, the supernatant
was sampled at 24 hour intervals for the kinetic evaluation of C3
production.
Measurement of C3 by ELISA
The levels of the C3 in the cell culture medium was measured
by a sandwich technique [18]. Briefly, the individual wells of a 96
well flat bottomed microtiter plate (Maxisorb Nunc, Mascia
Brunelli, Milano, Italy) were coated by an overnight incubation
with the purified IgG of the antiserum to C3 diluted 1:500 in
0.1 M Na2HCO3 pH 9.6 (200 pd/well). After washing with PBS
containing 0.1% Tween 20 and blocking with PBS containing 1%
BSA for one hour at 37°C, the bound antibodies were allowed to
react first with 200 j.Ll of cell culture supernatants for one hour at
37°C, and then with the biotin-labeled specific antibodies for an
additional hour at 37°C, followed by alkaline phosphatase-labeled
streptavidin (Jackson Laboratories, West Grove, PA, USA) di-
luted 1:8000. The enzymatic reaction was revealed using p-
nitrophenyl phosphate (1 g/m1) as substrate and reading was
performed with a Titertek Multiskan ELISA reader (Flow Labo-
ratories, Milano, Italy) at 405 nm. Control culture medium served
as blank. Calibration curves were set up with increasing amounts
of the purified component and sensitivity of the assay was 1 ng/ml.
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Fig. 1. Immunoalkaline staining of HMC culture with an anti-DR antibody to exclude contamination of monocyte-macrophages. HMC line #3 grown onto
plastic slides or human peritoneal macrophages (positive control) were stained with a mouse monoclonal anti-DR (A, C) or an irrelevant mouse
monoclonal antibody (B, D). The alkaline phosphatase was developed with New Fuchsin (red color). Reproduction of this figure in color was made
possible by a grant from Hoechst Italia Hospital Supply Department, Milan, Italy.
Hemolytic assay for C3
The hemolytic activity of C3 secreted by mesangial cells was
evaluated by a test system that included 50 p.l of 1gM-sensitized
sheep erythrocytes (3 >< 108 cells/mi), 200 .tl of culture superna-
tant and 7 p.l of human serum depleted of C3 by affinity
chromatography (Sigma Chemical Co.). The mixture was incu-
bated at 37°C for 30 minutes and the degree of lysis was measured
spectrophotometrically at 415 nm.
SDS-PAGE and immunoblot
The culture supernatants of mesangial cells either unstimulated
or treated with cytokines were analyzed by SDS-PAGE on a 7%
gel under non-reducing conditions according to Laemmli [201.
The samples were dialyzed against distilled water, lyophilized and
resuspended in the sample buffer prior to loading on the gel. After
completion of the run, the proteins were electrophoretically
transferred onto the nitrocellulose membrane (Schleicher &
Schuell Inc., Dassel, Germany) using a transblot semidry system
(Hoefer Scientific Instruments, San Francisco, CA, USA) and the
free binding sites were blocked with an overnight incubation with
PBS pH 7.4 containing 2% BSA. The nitrocellulose was then
exposed to goat IgG against C3 diluted 1:100 for one hour at 37°C
and subsequently to 1:1000 peroxidase-labeled rabbit antibodies
to goat IgU (Sigma Chemical Co.) for one additional hour. The
enhanced chemiluminescence (ECL) system purchased by Amer-
sham (Amity, Milano, Italy) was employed to develop the enzy-
matic reaction following the instructions of the manifacturer and
the chemiluminescence signal was detected by exposing the
nitrocellulose sheet to X-Omat AR films (Kodak, Rochester, NY,
USA).
Extraction of RNA
HMC pellets were treated with guanidinium denaturing solu-
tion (4 M guanidinium isothiocyanate, 25 m sodium citrate, pH 7;
0.5% Sarcosyl and 0.1 M 2-mercaptoethanol) and stored at —80°C.
Total cellular RNA was extracted by the single step acid guani-
dinium, phenol/chloroform extraction method [21]. Purity of
extracted RNA was checked by A2601280 reading and agarose-
formaldehyde denaturing gel electrophoresis to evaluate the
integrity of 28S and 18S bands.
Analysis of C3 transcript
Two micrograms of total RNA from each specimen were
reverse transcribed into cDNA by using the RNA-PCR kit
(Perkin-Elmer, Norwalk, CT, USA) in presence of RNasin and
oligo-dT as a universal primer for messenger RNAs. Reaction
proceeded for 15 minutes at 42°C and was stopped by increasing
temperature at 99°C for five minutes. Then, the reaction mixture
832 Montinaro et al: Biosynthesis of C3 by human mesangial cells
160
140
120
C" 100
U)
80
60
C 40
20
0
1
0
Fig. 3. Effect of IL-I on the basal synthesis of C3 by HMC. Cells were
stimulated with IL-113 at different concentration in basal medium for 72 hr.
Symbols are cell lines: (—LI—) #1; (U-) #2; (-—D--) #3. Values
represent mean se of three or four determinations. * P < 0.05, * * p <
0.01 versus basal.
was supplemented with deoxynucleotides, Taq polymerase, and
primers specific for the human C3 gene (donated by Dr. A. Rifai,
Providence, RI, USA). These primers were: downstream, CTT-
GAGATCTGTACCAGGTACC, and upstream, CTrGATG-
GTCTGCTCAATGGC, and included a 554 base pair long frag-
ment spanning from positions 4216 to 4769 nucleotide residue of
the eDNA [22]. Amplification was carried out in a termal cycler
(Perkin-Elmer) for 30 cycles (denaturing for 2 minutes at 95°C,
annealing for 2 minutes at 55°C, extension for 1 minute at 72°C).
Analysis of amplified products was performed by 3:1 NuSieve:
agarose (FMC BioProducts, Rockland, ME, USA) gel electro-
phoresis in TAE buffer and staining with ethidium bromide, The
intensity of bands of the amplified product of the housekeeping
gene GAPDH (primer downstream, TGGTATCGTGGAAGG-
Fig. 4. Kinetics of C3 production by HMC line #2 stimulated with IL-l/3
compared to basal conditions (I). Sampling of supernatants was performed
every 24 hours. Each value represents the mean of three determinations.
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Fig. 5. Effect of IL-6 on the basal synthesis of C3 by HMC. Symbols are cell
lines: (—LI—) #1; (---U---) #2; (— —. — —) #3. Cells were stimulated with
IL-6 at the indicated concentration in basal medium for 72 hr. Values are
mean SE of three determinations.
ACTCATGAC; primer upstream, ATTCGYFGTCATACCAG-
GA; fragment length 450 bp) was also considered.
To further confirm the sytnhesis of the specific C3 transcript by
HMC, total cellular RNA (30 jLg) was electrophoresed through
1% agarose denaturing gel containing 2.2 M formaldehyde, then
blotted onto nylon membrane (Nytran N, Schleicher & Schuell)
and hybridized with a specific probe for human C3. After washing
with a final stringency of 0.2x SSC, 0.1% SDS at 55°C for 15
minutes, the membrane was exposed to a X-Omat AR Kodak film.
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Fig. 2. Concentration of C3 in supernatants of three different HMC lines
cultured in basal medium for 72 hr. Values are mean SE of quadruplicate
determinations.
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Fig. 7. Effect of FBS and inhibition of protein synthesis on C3 detection on
supernatants. HMC (line #3) were kept in basal condition with RPMI
medium containing either FBS 0.5% or BSA 0.1% as protein carrier.
Other conditions consisted in IL-113 100 U/mI with or without cyclohexi-
mide 10 g/m1 in basal medium containing BSA 0.1%. All these culture
conditions were mantained for up to 72 hours.
The membrane was then stripped and rehybridized with a
GAPDH-specific probe.
The C3 probe used was the pHLC3.11 clone [22] obtained from
the American Type Culture Collection. The insert was removed
by double Sal I/Cia I digestion, which yelded two fragments of 2.4
and 1.8 kb for the presence of an internal Sal I site. The 1.8 kb
fragment was purified from agarose gel using a kit based on
microsilica beads (Geneclean, Bio 101, La Jolla, CA, USA), then
it was radiolabeled with 32P-dCFP (Amersham Italia, Milano,
Italy) by the random primer method (Megaprime DNA labeling
system, Amersham).
The purity of HMC used throughout this study was assessed by
standard immunoperoxidase techniques (Methods) to exclude
contamination with glomerular epithelial or endothelial cells.
Moreover, since bone marrow-derived cells may be resident
within the glomerulus, we performed an immunoalkaline phos-
phatase staining of HMC cultures with a monoclonal anti-DR
antibody. As shown in Figure 1 DR-positive cells were completely
absent in HMC cultures.
Three different HMC lines were tested for their ability to
secrete C3. Detectable levels of C3 were revealed in the superna-
tant of cells cultured in the absence of cytokines, though the
absolute amounts varied with the different cell lines (Fig. 2). The
same HMC line tested under different passage (3 to 7) showed
similar results (data not shown).
The intra- and interassay variations of the ELISA for C3 were
11% and 20%, respectively.
The secretion of C3 by HMC was up-regulated by IL-1/3, which
induced the cells to release an amount of C3 two- to fivefold
higher than that produced in basal conditions (Fig. 3). It is
interesting to note that the effect of the cytokine varied with the
HMC lines and no clear relationship was found between the C3
levels and the concentrations of IL-i j3. Thus, the cell lines #1 and
#3 showed the maximal response at low concentration of IL-13
(10 U/ml), whereas line #2 produced a significantly increased
amount of C3 only at higher concentration of IL-1/3. A kinetic
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Fig. 6. Effect of a combination of IL-1f3 (10 U/mi) and IL-6 (1000 U/mi) on
C3production by HMC (line #1). Cytokine stimulation was carried out for
72 hr, then supernatants were tested for C3 by ELISA. Values represent
mean of quadruplicate determinations. < 0.05, < 0.01 versus basal
or IL-6.
Fig. 8. Analysis of C3 gene expression by HMC (line #1). Total RNAs were
reverse transcribed into eDNA, then amplified by polymerase chain
reaction using primers specific for C3 (A) or the housekeeping gene
GAPDH (B). Amplified products were run in 3:1 NuSieve:agarose gel and
stained with etidium bromide. Lane 1: molecular weight standard (cIX 174
RF DNA Hae III); lane 2: basal; lane 3: IL-i (10 U/ml); lane 4: IL-6 (1000
UIml); lane 5: IL-i (10 U/ml) and IL-6 (1000 U/ml). (bp = base pairs).
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experiments were conducted in absence of FBS which might
interfere with the C3 ELISA and others in presence of the protein
synthesis inhibitor, cycloheximide. As shown in Figure 7, the
presence of FBS 0.5% in the medium did not appreciably modify
the C3 assay; moreover, inhibition of protein synthesis by cyclo-
heximide blocked the secretion and release of C3 induced by
IL-1f3 to an extent of 94%.
The culture supernatant of mesangial cells exhibited a detect-
able, albeit low, C3 hemolytic activity that was comparable with
that of pooled human sera at dilutions varying between 1/150,000
and 1/200,000.
The C3 specific gene expression was investigated by reverse
transcription of isolated RNA and subsequent polymerase chain
reaction of cDNA with specific primers. Low levels of the C3
transcript were present in HMC under basal conditions, whereas
the message was up-regulated following stimulation with IL-1J3
(Fig. 8). Analysis by Northern blot of total cellular RNA extracted
from HMC, confirmed that the message was an intregral 5.2 kb
long transcript (Fig. 9).
Finally, in accordance to the ELISA data and C3 gene expres-
sion analysis, parallel findings were obtained when the C3 pro-
duced by untreated or cytokine-stimulated HMC was analyzed by
SDS-PAGE and Western blot (Fig. 10).
Discussion
Fig. 9. Northern blotting analysis of RNA estracted from HMC. RNA (30
j.Lg/lane) from cell line #3 under basal conditions (lane 1) or stimulated
with IL-i 10 U/mI (lane 2) or IL-i 10 U/mI and IL-6 1000 U/mI (lane 3)
was electrophoresed through agarose gel, blotted onto nylon membrane
and hybridized with the 32P-radiolabelled 1.8 kb fragment of insert
obtained from pHC3.l1 clone. After exposure of an X-Omat film for one
week (A), the membrane was stripped and rehybridized with a GAPDH-
specific probe and exposed for 24 hours (B).
study of C3 secretion by the cell line #2 was performed in both
basal conditions and after stimulation by the optimal amount of
IL-i (1000 U/ml). Samples of supernatants were collected at 24
hour intervals and the level of C3 was assessed by ELISA. As
shown in Figure 4, the C3 synthetic rate, calculated by linear
regression analysis of three-time points for each condition, was
1.76 ng/106 cells/hr for the cells stimulated by IL-I, compared to
the basal value of 0.37 ng/106 cells/hr.
Stimulation of HMC by IL-6 did not induce an appreciable
change in the secretion of C3 by all three lines tested (Fig. 5).
However, experiments performed on the HMC line #1 showed
that IL-6 added at the concentration of 1000 U/ml together with
IL-i (10 U/ml) induced the release of an amount of C3 twofold
higher than that obtained in the presence of IL-i alone, suggest-
ing a synergistic effect of the two cytokines (Fig. 6).
Another stimulus tested was LPS. HMC line #3 cultured in
presence of LPS at concentration of 0.1 or i .tg/ml did not show
any significant increase in the basal C3 synthesis (data not shown).
To confirm that the C3 detected by ELISA in the supernatant
of cultures was really synthesized and secreted by HMC, some
The results of the present investigation provide evidence for the
secretion of C3 by HMC. This was demonstrated by: (i) immu-
noenzymatic quantitation of C3 on the supernatants of cell
cultures; (2) immunochemical demonstration of C3 in the culture
medium by SDS-PAGE and Western blot; and (3) expression of
specific messenger RNA for C3 by reverse transcription-poly-
merase chain reaction and Northern blot analysis. Our observa-
tion extends previous reports by Rother, Hänsch and Rauterberg
[14] and Shibata, Cosio and Birmingham [15], who showed
production of regulators of C system by HMC.
A point to emphasize is that HMC spontaneously secrete C3
even in basal conditions, though the extent of C production varied
with the different cell lines examined. Our findings are at variance
with those of Kaashoek et al [23], who were unable to reveal
secretion of C3 by unstimulated cells, but did show the presence
of a C3 transcript. The reasons for the discrepant finding are not
apparent, but they may be related to differences in culture
conditions. We have employed HMC cultured between passages 3
and 7 and, under this experimental condition, the magnitude of
C3 secretion was essentially similar for each HMC line. A certain
degree of variation was observed in the absolute amount of C3
secreted by the same cell line in separate experiments, but the
relative amount of C3 produced by the individual cell line
remained fairly constant since the ratio of values was essentially
unchanged. This finding suggests that the secretion of different
amounts of C3 is a feature of each cell line, and most likely reflects
a genetic background, a situation documented in inbreed mouse
strains [8].
The stimulatory activity of IL-i/3 on C3 secretion by HMC is
not surprising, since this cytokine exerts a similar effect on
cultured hepatocytes, which are stimulated to release a substantial
amount of acute phase proteins [4, 24]. IL-la seems to have an
effect on HMC comparable to that of IL-113 (data not shown) in
agreement with similar data reported by Kaashoek et a! [23].
These findings are relevant in the pathophysiology of mesangial
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CFig. 10. Immunoblot analysis of C3 in the
culture supernatant. The lyophilized samples
corresponding to 1 ml of the culture medium
were run on 7% acrylamide gel under non-
reducing conditions and blotted onto
nitrocellulose membrane. A 5 ng of purified C3;
B medium of unstimulated cells; C medium of
cells treated with IL-i (10 U/mI); D medium of
cells treated with IL-i (10 U/mI) and IL-6
(1000 U/mI).
cells and may contribute to explain, at least in part, the prom-
flammatory effect of IL-i in experimental models of various
glomerular diseases [25—31].
IL-6, the other cytokine tested, did not influence the spontane-
ous production of C3. One possible explanation for this finding is
that HMC lack the receptor for this cytokine, although the
increased incorporation of 3H-thymidine by mesangial cells
treated with IL-6 does not support this possibility [32, 331.
Furthermore, HMC respond to IL-6 with an increased secretion
of C3 when the cytokine is added to the cell as a mixture with IL-i.
A synergistic effect of the two cytokines was already reported in an
experimental model of IgA nephropathy in mice whereby the
glomerular response to deposited IgA immune complexes and,
more specifically, the intensity of glomerular C3 deposits and the
level of C3 transcript strongly increased with a combined treat-
ment with IL-i and IL-6 [31, 34]. On the other hand, the course
of the disease in this experimental model was not modified and, if
anything, was milder in mice treated with IL-6 alone. It is
therefore possible that IL-6 may have a different effect on the
mesangium depending on whether or not an inflammatory process
is established. The local presence of IL-i may favor the deleteri-
ous effect of IL-6, which otherwise would be ineffective or even
protective.
The role played by C components produced by HMC remains
to be elucidated. There is no doubt that these components can
only have a short range of action, given the low amount produced
by the cells, and hence can only modulate pathogenetic mecha-
nisms in a local fashion. Our finding that the C3 secreted by
mesangial cells had a low hemolytic activity, though readily
detectable by ELISA, can in part be explained by the different
sensitivity of the two assays, but also by the fact that a substantial
portion of C3 is enzymatically degraded and, consequently no
longer hemolytically active while being still measurable by ELISA.
However, this does not exclude that the C3 fragments may exhibit
proinflammatory functions more relevant to the pathological
processes involving the glomeruli, though these functions are
more difficult to assess under our experimental conditions. The
recent observation by Lianos and Zanglis [35] that fragments of
C3, C3a and C3b, can stimulate rat mesangial cells to synthesize
PGE2 and PAF would suggest that a vicious circle can be
established whereby cytokines, C components, PAF and eico-
sanoids, all produced locally and acting by autocrine or paracrine
modalities, contribute to tissue injury. The finding by the same
group [36] that the local production of PAF is reduced in
decomplemented animals in an experimental model of rat gb-
merular immune injury further supports the importance of C in
the pathogenesis of the glomerular lesions. With regard to human
diseases, our finding may suggest that, at least in some istances
characterized by glomerular deposition of C3 without detectable
imniunoglobulins [37, 381, local production of C3 within mesan-
gium could play a role.
In conclusion, HMC in culture express the specific C3 gene,
produce detectable levels of mature C3 and release this protein in
the culture medium. Cytokines such as IL-i and IL-6 modulate
this response increasing the basal C3 production.
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